Ascletis Pharma (OTCMKTS:ASCLF) Trading Up 4.8% – Should You Buy?

Ascletis Pharma Inc. (OTCMKTS:ASCLF)’s share price was up 4.8% during trading on Tuesday . The stock traded as high as $2.20 and last traded at $2.20. Approximately 200 shares changed hands during trading, a decline of 94% from the average daily volume of 3,273 shares. The stock had previously closed at $2.10.

Ascletis Pharma Price Performance

The stock has a 50-day moving average of $2.00 and a two-hundred day moving average of $1.72.

Ascletis Pharma Company Profile

Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.

The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).